Nabumetone Tablet, Film Coated
Product Images NDC 69097-965

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 69097-965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Nabumetone 1)

Chemical structure of Nabumetone, showing its molecular formula C15H16O2 and molecular weight 228.3. The diagram displays the arrangement of atoms and bonds characteristic of the Nabumetone molecule.*

FDA Label Image

6mna (Nabumetone 2)

Chemical structure of Nabumetone shown as a 4-methoxy-2-naphthyl derivative with a propanoic acid side chain, corresponding to the active ingredient Nabumetone.*

FDA Label Image

Figure (Nabumetone 3)

A line chart depicting Nabumetone active metabolite (6MNA) plasma concentrations over time at steady state following once-daily dosing of 1000 mg and 2000 mg. The graph shows concentrations in mcg/mL on the vertical axis and time in hours on the horizontal axis, including shaded areas representing ±2 standard deviations for both dosages.*

FDA Label Image

This Is A Picture Of The Label Nabumetone Tablets, Usp, 750 mg, 100 Count (Nabumetone 500 mg Asc)

Nabumetone Tablets, USP 500 mg film-coated oral tablets label. The label shows the NDC number 69097-965-07 and states the package contains 100 tablets. It includes storage instructions, a note for pharmacists about the Medication Guide, and manufacturer information: Ascent Pharmaceuticals, Inc., with manufacturing for Cipla USA Inc. The label features a QR code and a barcode on the right side.*

FDA Label Image

This Is A Picture Of The Label Nabumetone Tablets, Usp, 500 mg, 100 Count (Nabumetone 500 mg Inv)

Nabumetone Tablets, USP 500 mg film-coated oral tablets label, containing 100 tablets. The label indicates storage instructions, manufacturer details including Cipla USA Inc., and emphasizes that each patient must receive a medication guide. The packaging includes a barcode and QR code, with the revision date 03/2020.*

FDA Label Image

This Is A Picture Of The Label Nabumetone Tablets, Usp, 500 mg, 100 Count (Nabumetone 750 mg Asc)

Nabumetone 750 mg tablets, USP, film coated oral tablets in a 100-tablet bottle packaging label. Manufactured by Ascent Pharmaceuticals, Inc. for Cipla USA Inc. The label includes storage instructions, a notice for pharmacists to provide a Medication Guide, and a barcode. The label design features prominent dosage information in white text on a teal background and the Cipla logo in blue.*

FDA Label Image

This Is A Picture Of The Label Nabumetone Tablets, Usp, 500 mg, 100 Count (Nabumetone 750 mg Inv)

Nabumetone Tablets, USP 750 mg film-coated tablets, packaged in a container of 100 tablets. The label shows the NDC number 69097-966-07 and indicates prescription use only. Manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd., for Cipla USA Inc., located in Warren, NJ. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.